Triumph Bancorp, Inc. (TBK) EPS Estimated At $0.59; Maximus (MMS) Shorts Decreased By 11.81%

March 17, 2018 - By Marguerite Chambers

Maximus Inc (NYSE:MMS) had a decrease of 11.81% in short interest. MMS’s SI was 1.03M shares in March as released by FINRA. Its down 11.81% from 1.17 million shares previously. With 433,200 avg volume, 2 days are for Maximus Inc (NYSE:MMS)’s short sellers to cover MMS’s short positions. The SI to Maximus Inc’s float is 1.6%. The stock increased 0.40% or $0.27 during the last trading session, reaching $68.11. About 773,495 shares traded or 65.29% up from the average. MAXIMUS, Inc. (NYSE:MMS) has risen 15.99% since March 17, 2017 and is uptrending. It has underperformed by 0.71% the S&P500.

Analysts expect Triumph Bancorp, Inc. (NASDAQ:TBK) to report $0.59 EPS on April, 18.They anticipate $0.57 EPS change or 2,850.00% from last quarter’s $0.02 EPS. TBK’s profit would be $12.29M giving it 18.47 P/E if the $0.59 EPS is correct. After having $0.54 EPS previously, Triumph Bancorp, Inc.’s analysts see 9.26% EPS growth. The stock increased 0.35% or $0.15 during the last trading session, reaching $43.6. About 260,948 shares traded or 105.16% up from the average. Triumph Bancorp, Inc. (NASDAQ:TBK) has risen 39.25% since March 17, 2017 and is uptrending. It has outperformed by 22.55% the S&P500.

MAXIMUS, Inc. provides business process services to government health and human services programs in the United States, the United Kingdom, Australia, Canada, and Saudi Arabia. The company has market cap of $4.44 billion. The companyÂ’s Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Fit for Work Service. It has a 20.33 P/E ratio. The Company’s services include health insurance exchange customer contact center activities and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; health plan oversight; eHealth solutions with the Medigent product suite; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services.

Investors sentiment decreased to 1.1 in Q3 2017. Its down 0.29, from 1.39 in 2017Q2. It dropped, as 22 investors sold MAXIMUS, Inc. shares while 77 reduced holdings. 42 funds opened positions while 96 raised stakes. 57.34 million shares or 3.44% less from 59.39 million shares in 2017Q2 were reported. Cambiar Invsts Limited Liability Corporation reported 0.06% in MAXIMUS, Inc. (NYSE:MMS). Cetera Limited Com reported 0.02% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Mutual Of America Capital Ltd Liability Corporation owns 107,776 shares for 0.11% of their portfolio. Systematic Finance Management L P accumulated 25,070 shares. Arizona State Retirement owns 36,741 shares. Sei Invests reported 22,444 shares. Northwestern Mutual Wealth Com invested in 150 shares or 0% of the stock. Fuller & Thaler Asset Mngmt invested in 1,200 shares or 0% of the stock. Vanguard Gru Inc Inc owns 5.98 million shares or 0.02% of their US portfolio. Teacher Retirement Systems Of Texas accumulated 5,352 shares. Alphaone Services Limited Liability Co reported 0.01% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Panagora Asset Management invested 0.06% of its portfolio in MAXIMUS, Inc. (NYSE:MMS). Weaver C Barksdale Assocs reported 201 shares. Clarivest Asset Management Limited Liability reported 0% stake. Fund Mngmt Sa invested 0.05% of its portfolio in MAXIMUS, Inc. (NYSE:MMS).

Among 8 analysts covering MAXIMUS (NYSE:MMS), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. MAXIMUS had 36 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Hold” rating by Robert W. Baird given on Wednesday, January 3. The stock of MAXIMUS, Inc. (NYSE:MMS) has “Buy” rating given on Friday, December 4 by Stifel Nicolaus. Robert W. Baird maintained the stock with “Hold” rating in Monday, October 2 report. The rating was downgraded by Maxim Group on Friday, May 5 to “Hold”. Jefferies maintained MAXIMUS, Inc. (NYSE:MMS) rating on Thursday, September 28. Jefferies has “Hold” rating and $63.0 target. Canaccord Genuity maintained MAXIMUS, Inc. (NYSE:MMS) on Friday, November 10 with “Hold” rating. The rating was downgraded by Sidoti on Friday, August 7 to “Neutral”. The company was maintained on Tuesday, May 31 by Jefferies. The rating was maintained by Canaccord Genuity with “Hold” on Friday, October 13. Canaccord Genuity maintained it with “Hold” rating and $71.0 target in Wednesday, December 13 report.

Since September 19, 2017, it had 0 insider purchases, and 6 selling transactions for $4.79 million activity. Shares for $2.04M were sold by MONTONI RICHARD A on Tuesday, February 20. $194,400 worth of MAXIMUS, Inc. (NYSE:MMS) shares were sold by Andrekovich Mark. On Tuesday, September 19 Caswell Bruce sold $506,253 worth of MAXIMUS, Inc. (NYSE:MMS) or 8,000 shares. $195,840 worth of MAXIMUS, Inc. (NYSE:MMS) was sold by FRANCIS DAVID on Thursday, October 5. $1.63 million worth of MAXIMUS, Inc. (NYSE:MMS) shares were sold by RUDDY RAYMOND B.

Triumph Bancorp, Inc., a financial holding company, provides banking and commercial finance services and products to businesses in the United States. The company has market cap of $908.01 million. The firm operates through four divisions: Banking, Factoring, Asset Management, and Corporate. It has a 24.08 P/E ratio. It offers depository products, including checking, savings, and money market accounts, as well as certificates of deposit; and commercial and industrial loans, loans to purchase capital equipment, and business loans for working capital and operational purposes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News